# Spain Vascular Embolization Market > Spain Vascular Embolization Market Research Report: Size, Share, Trend Analysis By Embolization Technique (Coiling Devices, Non-coiling Devices) and By Applications (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.9% - **2024:** $ 52.2 Million - **2025:** $ 57.37 Million - **2035:** $ 147.49 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US), AngioDynamics (US) **Report ID:** MRFR/HC/50303-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/spain-vascular-embolization-market-52061 --- ## Market Summary ## **Spain Vascular Embolization Market Overview** As per MRFR analysis, the Spain Vascular Embolization Market Size was estimated at 23.77 (USD Million) in 2023. The Spain Vascular Embolization Market Industry is expected to grow from 26.12(USD Million) in 2024 to 65 (USD Million) by 2035. The Spain Vascular Embolization Market CAGR (growth rate) is expected to be around 8.639% during the forecast period (2025 - 2035). ### **Key Spain Vascular Embolization Market Trends Highlighted** A variety of critical factors is fueling growth in the Spain Vascular Embolization Market. An important market driver is the growing prevalence of vascular diseases and conditions necessitating embolisation procedures. The utilization of embolisation technologies has increased as a result of the increasing demand for minimally invasive procedures among the Spanish population, which is ageing. In addition, advancements in medical technology, such as the creation of novel embolisation agents and devices, are improving the safety and efficacy of procedures. Vascular embolisation is becoming a more popular treatment option in Spain, as the healthcare sector is increasingly concerned with optimizing healthcare costs and enhancing patient outcomes.  To capitalize on opportunities in the Spain Vascular Embolisation Market, it is necessary to investigate the integration of digital technologies, including telemedicine and AI, into treatment planning and monitoring. To enhance patient management and expedite workflows, hospitals and clinics are seeking to implement innovative solutions. Additionally, the increasing awareness of patients regarding various treatment options presents an opportunity for healthcare providers and manufacturers.  Recent developments suggest that Spain is transitioning to personalized medicine, which involves treatment strategies for vascular conditions that are more specifically tailored to the unique needs of each patient. Further, the research and development of novel embolisation products and techniques are being facilitated by collaborative efforts among hospitals, academic institutions, and industry players.This pattern is anticipated to drive additional enhancements in patient satisfaction and clinical outcomes for patients who undergo vascular procedures in Spain. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **Spain Vascular Embolization Market Drivers** Increasing Prevalence of Cancer Patients in Spain The rising number of cancer patients in Spain is a significant driver for the Spain Vascular Embolization Market Industry. According to the Spanish Association Against Cancer, approximately 1 in 2 men and 1 in 3 women will be diagnosed with cancer in their lifetime, with an estimated 280,000 new cases expected in 2023 alone. This surge in patients needing innovative treatment options, including vascular embolization techniques, aligns with the escalating demand for minimally invasive procedures to manage tumor-related complications.Established medical institutions like La Paz University Hospital and Vall d'Hebron University Hospital are enhancing their vascular embolization services, which further drives market growth as they adopt advanced embolization technologies to treat conditions stemming from cancer. Technological Advancements in Embolization Procedures The continuous technological advancements in embolization procedures are crucial for the growth of the Spain Vascular Embolization Market Industry. Recent innovations in embolization agents and delivery systems have led to improved efficacy and reduced complications. Notably, Spanish companies like B. Braun Medical have been at the forefront of developing new embolic materials that enhance the precision of these medical procedures. According to industry reports, the adoption of advanced techniques, such as Transarterial Chemoembolization (TACE), has grown by 30% over the past 5 years, indicating an increasing reliance on these technologies by healthcare providers across Spain. Supportive Government Initiatives and Regulations The Spanish government has introduced multiple initiatives to improve healthcare services, including the facilitation of the Spain Vascular Embolization Market Industry. Recent policy changes emphasize the need for innovative treatment options in public health facilities, thus endorsing vascular embolization as a crucial intervention for various conditions, including tumors and vascular malformations. With funding provided through the European Union Next Generation Fund, hospitals across Spain are upgrading their infrastructure and technology, ensuring wider access to such procedures.This funding is projected to increase the number of vascular embolizations by 25% in public hospitals by 2025, thereby stimulating market growth. Growing Aging Population in Spain The increasing aging population in Spain is another significant driver for the Spain Vascular Embolization Market Industry. By 2025, it is estimated that over 25% of the Spanish population will be aged 65 or older. This demographic is particularly susceptible to various vascular disorders, including aneurysms and varicose veins, increasing the demand for vascular embolization procedures. Research conducted by the National Statistics Institute indicates that the incidence of vascular diseases rises sharply with age, creating a critical need for innovative solutions in treating these conditions.This growing demand is supported by healthcare facilities such as the Complejo Hospitalario Universitario de Santiago, which is investing in advanced embolization technologies to meet this need. ## **Spain Vascular Embolization Market Segment Insights** ### **Vascular Embolization Market Embolization Technique Insights** The Spain Vascular Embolization Market, particularly focusing on the Embolization Technique segment, is evolving significantly due to the increasing prevalence of vascular diseases and the advancements in medical technologies. This market segment is primarily categorized into Coiling Devices and Non-coiling Devices, both of which play crucial roles in therapeutic interventions. Coiling Devices, which are commonly used for aneurysm treatment, are essential as they provide a minimally invasive approach to occlude blood vessels, thereby preventing hemorrhagic events. The introduction of innovative materials and designs in coiling devices has led to enhanced efficacy and fewer procedure-related complications, making them a preferred choice in various clinical settings.  On the other hand, Non-coiling Devices, which include various embolic agents and particles, are vital for treating conditions like arteriovenous malformations and tumors. The flexibility and adaptability of these devices allow for tailored treatment plans for patients, contributing to improved clinical outcomes. The growing preference for less invasive procedures among patients and physicians further drives the demand for both coiling and non-coiling techniques. Moreover, the Spain Vascular Embolization Market is shaped by a robust healthcare framework and increasing investments in medical technology.  Government initiatives to improve healthcare services and increase the accessibility of advanced medical treatments bolster market growth, reflecting the continuous endeavor to enhance patient care in Spain. Both coiling and non-coiling devices are integral to the advancement of vascular embolization procedures, as they provide new therapeutic options and improve surgical outcomes. As hospitals and clinics increasingly adopt these technologies, the market is expected to witness steady growth, propelled by the rising awareness and availability of various embolization techniques catering to the diverse needs of patients. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ### **Vascular Embolization Market Application Insights** The Application segment of the Spain Vascular Embolization Market is a crucial aspect, housing various fields such as Peripheral Vascular Disease, Oncology, Neurology, Urology, and Other applications. Peripheral Vascular Disease plays a significant role, given the rising aging population in Spain and the associated increase in vascular issues, thus addressing a major public health concern. Similarly, the Oncology segment is critical, driven by the growing incidence of cancer, necessitating advanced embolization techniques for targeted tumor treatment.Neurology also holds importance, with procedures aimed at treating conditions like arteriovenous malformations, reflecting the increased focus on neurovascular healthcare.  Urology applications address concerns like renal tumors and benign prostatic hyperplasia, showcasing the versatility of embolization methods in treating diverse medical conditions. The Other category incorporates additional uses, broadening the overall scope of the Vascular Embolization Market. This segment shows a positive trend fueled by technological advancements and a rising demand for minimally invasive procedures.Collectively, these applications highlight the multifaceted nature of the market, reflecting varying healthcare needs across Spain and contributing to the overall evolution of the Spain Vascular Embolization Market. ## **Spain Vascular Embolization Market Key Players and Competitive Insights** The Spain Vascular Embolization Market is characterized by a range of competitive dynamics that influence both market growth and product innovation. Importantly, this market has seen increased competition due to technological advancements and the need for effective interventions in various vascular procedures. A diverse array of companies is actively participating, each bringing unique strengths in terms of product offerings, distribution networks, and customer engagement strategies. The growing prevalence of vascular disorders, along with a rising demand for minimally invasive procedures, propels the market forward.  Companies striving to enhance their market positions are focusing on innovative solutions, strong collaborations with healthcare providers, and targeting regulatory approvals for their products, which significantly shapes the competitive landscape in Spain. AngioDynamics holds a notable position within the Spain Vascular Embolization Market, recognized for its strong product portfolio that includes advanced embolization devices and technologies tailored to meet the specific needs of healthcare professionals. The company benefits from a well-established distribution network and strategic partnerships that enhance its market reach across Spain. Known for its commitment to innovation, AngioDynamics is investing in research and development to further improve its offerings in vascular embolization, making them more effective and user-friendly for clinicians.  The company's strengths lie in its ability to respond to market trends and patient needs rapidly, ensuring that it stays ahead in the competitive arena by delivering reliable products associated with significant clinical outcomes.Asahi Intecc is another influential player within the Spain Vascular Embolization Market, renowned for its specialized medical devices and catheters that cater to a variety of vascular interventions. The company has carved a strong presence in the region, thanks to its dedication to quality and the effectiveness of its products.  Asahi Intecc's strengths include a robust portfolio featuring advanced angiographic systems and deliverable devices that support a broad range of procedures, enabling healthcare professionals to perform complex embolization treatments efficiently. Additionally, their strategic focus on expanding their presence through collaborations and potential mergers or acquisitions positions them favorably in the market, amplifying their capabilities in delivering innovative solutions to the Spanish healthcare sector. The firm’s commitment to continual improvement and adaptation to the evolving needs of the vascular embolization landscape makes it a key competitor in Spain. **Key Companies in the Spain Vascular Embolization Market Include** ## **Spain Vascular Embolization Market Industry Developments** The Spain Vascular Embolization Market has seen notable developments, particularly in the competitive landscape involving key players such as AngioDynamics, B. Braun Melsungen, Johnson and Johnson, Medtronic, and Boston Scientific. In November 2022, Abbott Laboratories announced the launch of a new vascular embolization device that aims to enhance procedural efficiency and patient outcomes, addressing the growing need for advanced treatment options. Furthermore, in July 2022, Cook Medical expanded its distribution agreement with a local Spanish firm to improve access to its innovative products, demonstrating the increasing demand within the market.  The market is projected to grow significantly, with a valuation rise attributed to technological advancements and expanding healthcare facilities across Spain. Despite the challenges posed by economic factors post-COVID-19, the vascular embolization segment continues to attract investment, as evidenced by Terumo Corporation’s strategic partnership with local healthcare providers for improved service delivery. Over the past few years, increasing occurrences of vascular diseases in Spain have further bolstered the necessity for embolization procedures, making it a pivotal focus area for innovation and investment among leading companies in the field. ## **Spain Vascular Embolization Market Segmentation Insights** ### **Vascular Embolization Market Embolization Technique****Outlook** ### **Vascular Embolization Market Application****Outlook** ## Market Drivers ### Growing Awareness and Education The rising awareness of vascular health issues among the Spanish population is significantly impacting the vascular embolization market. Educational campaigns and initiatives by healthcare organizations are informing patients about the risks associated with vascular diseases and the benefits of embolization procedures. This increased awareness is likely to lead to earlier diagnosis and treatment, thereby expanding the patient base for embolization therapies. The vascular embolization market is expected to see a positive shift as more individuals seek out these procedures. Surveys indicate that nearly 60% of the population is now aware of vascular conditions, which is a substantial increase compared to previous years. This trend suggests a growing demand for embolization services, potentially leading to a market growth rate of around 7% annually. ### Increased Healthcare Expenditure Spain's rising healthcare expenditure is a crucial factor driving the vascular embolization market. The government and private sectors are investing more in healthcare infrastructure, which includes advanced treatment modalities for vascular conditions. This increase in funding allows for better access to innovative embolization techniques and devices. Reports indicate that healthcare spending in Spain is expected to reach approximately €200 billion by 2026, reflecting a commitment to improving patient care. The vascular embolization market stands to gain from this trend, as more resources are allocated to specialized treatments. Enhanced funding not only facilitates the procurement of advanced technologies but also supports training for healthcare professionals, ensuring that patients receive high-quality care. ### Supportive Regulatory Environment The regulatory landscape in Spain is becoming increasingly favorable for the vascular embolization market. Authorities are streamlining the approval processes for new medical devices and procedures, which encourages innovation and market entry. Recent initiatives aimed at expediting the review of embolization technologies are likely to enhance competition and improve patient access to cutting-edge treatments. The vascular embolization market is poised to benefit from these regulatory changes, as they facilitate quicker adoption of new therapies. With a supportive framework in place, companies are more inclined to invest in research and development, potentially leading to a broader range of embolization options for healthcare providers. This regulatory support may contribute to an estimated market growth of 6% over the next few years. ### Advancements in Medical Technology Technological innovations in the field of vascular embolization are significantly influencing the market in Spain. The introduction of minimally invasive techniques and advanced embolic agents has improved patient outcomes and reduced recovery times. For instance, the development of new materials and delivery systems has enhanced the precision of embolization procedures. The vascular embolization market is witnessing a surge in the adoption of these technologies, which are often associated with lower complication rates. As hospitals and clinics invest in state-of-the-art equipment, the market is projected to grow, with estimates suggesting a valuation of over €500 million by 2027. This technological evolution not only enhances procedural efficacy but also attracts more patients seeking less invasive treatment options. ### Rising Incidence of Vascular Diseases The increasing prevalence of vascular diseases in Spain is a primary driver for the vascular embolization market. Conditions such as aneurysms, arteriovenous malformations, and peripheral artery disease are becoming more common, leading to a heightened demand for effective treatment options. According to recent health statistics, vascular diseases account for a significant portion of morbidity and mortality in the country. This trend is likely to propel the market forward, as healthcare providers seek innovative solutions to manage these conditions. The vascular embolization market is expected to benefit from this growing patient population, with an anticipated growth rate of approximately 8% annually over the next few years. As awareness of these diseases increases, so does the need for advanced embolization techniques, further driving market expansion. ## Future Outlook The [Vascular Embolization Market](https://www.marketresearchfuture.com/reports/vascular-embolization-market-11872) in Spain is projected to grow at a 9.9% CAGR from 2025 to 2035, driven by technological advancements and increasing demand for minimally invasive procedures. **New opportunities:** - Development of biodegradable embolic agents for enhanced patient safety. - Expansion of telemedicine platforms for remote embolization consultations. - Investment in AI-driven imaging technologies to improve procedural accuracy. By 2035, the vascular embolization market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing) In the Spain vascular embolization market, coiling devices hold the largest market share, reflecting their established use in various vascular procedures. Their reliability and effectiveness in treating conditions such as aneurysms have contributed to their dominant position within the segment. Non-coiling devices, although smaller in market share compared to coiling devices, are witnessing rapid growth due to advancements in technology and increasing clinical applications. Growth trends indicate that non-coiling devices are becoming more favored as new types are developed that enhance procedural outcomes. Factors driving this trend include the rise in minimally invasive procedures, growing awareness about vascular diseases, and enhancements in product efficacy and safety profiles. This shift in preference is expected to reshape the competitive landscape of the Spain vascular embolization market. Devices: Coiling (Dominant) vs. Non-coiling (Emerging) Coiling devices are often seen as the backbone of the vascular embolization market due to their proven performance and extensive clinical usage over the years. They provide a versatile solution, specifically in treating aneurysms, which is critical in the vascular landscape. In contrast, non-coiling devices are rapidly emerging as a preferred option among healthcare professionals, driven by innovative designs and improved functionality. These devices include various materials and technologies that cater to a broader range of vascular anomalies, indicating a significant shift towards expanded application opportunities. As non-coiling technology continues to evolve, it is expected to capture a larger market share, complementing the established coiling methods. ### By Application: Oncology (Largest) vs. Peripheral Vascular Disease (Fastest-Growing) The Spain vascular embolization market exhibits a diverse application landscape, with oncology emerging as the largest segment, commanding a significant share. Peripheral vascular disease is gradually gaining traction, indicating a shift in preference towards addressing this urgent health concern. Other notable applications include neurology and urology, which, while important, are currently overshadowed by the dominant presence of oncology in overall market distribution. Growth trends in the application segment are being driven by an increasing incidence of cancers and vascular disorders, prompting advancements in embolization technologies. The rise of minimally invasive procedures and technological innovations further fuel this growth. The urgency to manage peripheral vascular disease is notably accelerating its growth, setting the stage for increased competition and development within the segment. Oncology (Dominant) vs. Peripheral Vascular Disease (Emerging) Oncology remains a dominant application in the Spain vascular embolization market, leveraging advancements in targeted therapies and innovative embolic agents. Its strong foothold is underscored by increasing cancer prevalence and heightened awareness regarding early interventions. Conversely, peripheral vascular disease represents an emerging segment, gaining momentum as healthcare systems prioritize treatment options to manage chronic diseases effectively. This segment is characterized by a growing demand for efficacious therapeutic alternatives, with new technologies entering the market to facilitate enhanced patient outcomes. The evolution of these segments reflects the dynamic nature of the market, responding to both clinical needs and patient demand. ## Competitive Benchmarking The vascular embolization market in Spain is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an increasing prevalence of vascular diseases, advancements in medical technology, and a growing emphasis on minimally invasive procedures. Major players such as Medtronic (US), Boston Scientific (US), and Terumo Corporation (JP) are strategically positioned to leverage these trends. Medtronic (US) focuses on innovation through the development of advanced embolization devices, while Boston Scientific (US) emphasizes partnerships to enhance its product offerings. Terumo Corporation (JP) is actively pursuing regional expansion to capture a larger market share, thereby collectively shaping a competitive environment that is increasingly reliant on technological advancements and strategic collaborations.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of Spain's regulatory landscape. The market appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to thrive, while larger companies consolidate their positions through strategic acquisitions and partnerships, thereby enhancing their competitive edge. In October Medtronic (US) announced the launch of a new embolization device designed specifically for the treatment of uterine fibroids. This innovation is expected to significantly improve patient outcomes and reflects Medtronic's commitment to advancing minimally invasive treatment options. The strategic importance of this launch lies in its potential to capture a larger share of the growing market for uterine fibroid treatments, which is increasingly sought after by patients and healthcare providers alike. In September Boston Scientific (US) entered into a partnership with a leading Spanish healthcare provider to enhance the distribution of its embolization products. This collaboration is likely to strengthen Boston Scientific's market presence in Spain, allowing for better access to its innovative solutions. The strategic significance of this partnership is underscored by the potential for increased sales and improved patient access to cutting-edge embolization technologies. In August Terumo Corporation (JP) expanded its manufacturing capabilities in Spain by investing €10 million in a new facility dedicated to producing embolization products. This move not only enhances Terumo's operational efficiency but also aligns with the growing demand for locally manufactured medical devices. The strategic importance of this investment is evident in its potential to reduce lead times and improve supply chain reliability, which are critical factors in the competitive landscape. As of November current trends in the vascular embolization market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into medical devices. Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate in order to innovate and meet evolving market demands. Looking ahead, competitive differentiation is likely to shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This evolution suggests that companies that prioritize these aspects will be better positioned to thrive in an increasingly competitive environment. ## Recent News & Developments The Spain Vascular Embolization Market has seen notable developments, particularly in the competitive landscape involving key players such as AngioDynamics, B. Braun Melsungen, Johnson and Johnson, Medtronic, and Boston Scientific. In November 2022, Abbott Laboratories announced the launch of a new vascular embolization device that aims to enhance procedural efficiency and patient outcomes, addressing the growing need for advanced treatment options. Furthermore, in July 2022, Cook Medical expanded its distribution agreement with a local Spanish firm to improve access to its innovative products, demonstrating the increasing demand within the market.  The market is projected to grow significantly, with a valuation rise attributed to technological advancements and expanding healthcare facilities across Spain. Despite the challenges posed by economic factors post-COVID-19, the vascular embolization segment continues to attract investment, as evidenced by Terumo Corporation’s strategic partnership with local healthcare providers for improved service delivery. Over the past few years, increasing occurrences of vascular diseases in Spain have further bolstered the necessity for embolization procedures, making it a pivotal focus area for innovation and investment among leading companies in the field. ## Report Scope | MARKET SIZE 2024 | 52.2(USD Million) | | --- | --- | | MARKET SIZE 2025 | 57.37(USD Million) | | MARKET SIZE 2035 | 147.49(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.9% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US), AngioDynamics (US) | | Segments Covered | Technique, Application | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the vascular embolization market. | | Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in vascular embolization technologies and regulatory adaptations. | | Countries Covered | Spain | ## Frequently Asked Questions **Q: What is the current valuation of the vascular embolization market in Spain as of 2024?** A: The market valuation was $52.2 Million in 2024. **Q: What is the projected market size for vascular embolization in Spain by 2035?** A: The projected valuation for 2035 is $147.49 Million. **Q: What is the expected CAGR for the vascular embolization market in Spain during the forecast period 2025 - 2035?** A: The expected CAGR is 9.9% during the forecast period 2025 - 2035. **Q: Which companies are the key players in the Spain vascular embolization market?** A: Key players include Medtronic, Boston Scientific, Terumo Corporation, Johnson & Johnson, Stryker Corporation, B. Braun Melsungen AG, Cook Medical, Abbott Laboratories, and AngioDynamics. **Q: What are the main segments of the vascular embolization market in Spain?** A: The main segments include Technique and Application, with subcategories like Coiling Devices and Peripheral Vascular Disease. **Q: How did the valuation of coiling devices compare to non-coiling devices in 2024?** A: In 2024, coiling devices were valued at $20.88 Million, while non-coiling devices reached $31.32 Million. **Q: What is the valuation range for oncology applications in the vascular embolization market in Spain?** A: The valuation for oncology applications ranged from $15.0 Million to $40.0 Million. **Q: What is the expected growth trend for the vascular embolization market in Spain?** A: The market appears to be on a growth trajectory, with a projected increase to $147.49 Million by 2035. **Q: What was the valuation for neurology applications in the vascular embolization market in 2024?** A: The valuation for neurology applications was $12.0 Million in 2024. **Q: How does the valuation of peripheral vascular disease applications compare to urology applications in 2024?** A: In 2024, peripheral vascular disease applications were valued at $10.0 Million, whereas urology applications were valued at $8.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/spain-vascular-embolization-market-52061*